Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001973141-24-000459
Filing Date
2024-09-17
Accepted
2024-09-17 16:11:23
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 2917
  Complete submission text file 0001973141-24-000459.txt   4561
Mailing Address 825 INDUSTRIAL ROAD, STE. 300 SAN CARLOS CA 94070
Business Address 825 INDUSTRIAL ROAD, STE. 300 SAN CARLOS CA 94070 650-837-0111
Vaxcyte, Inc. (Subject) CIK: 0001649094 (see all company filings)

EIN.: 464233385 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-39323 | Film No.: 241304358
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O SQZ BIOTECHNOLOGIES COMPANY 200 ARSENAL YARDS BOULEVARD, SUITE 210 WATERTOWN MA 02472
Business Address
Loxam Teri (Reporting) CIK: 0001829111 (see all company filings)

Type: 144